Associate Professor Natalie Staplin
Natalie Staplin
PhD
Senior Statistician
Natalie is a Senior Statistician within the Renal Studies Group at the Clinical Trials Service Unit & Epidemiological Studies Unit (CTSU). She is also a lecturer on the MSc in Global Health Science and Epidemiology.
Natalie joined CTSU in 2012 after completing an undergraduate degree in Mathematics with Actuarial Science and a PhD in Statistics.
Her current research interests are epidemiological analyses of patients with chronic kidney disease to identify risk factors associated with vascular events or progression to end-stage renal disease.
She is particularly interested in competing risks methodology and the use of directed acyclic graphs in observational analyses.
Recent publications
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Journal article
Malijan GB. et al, (2026), Am J Kidney Dis, 87, 553 - 563.e1
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Journal article
Zhu D. et al, (2026), Am J Kidney Dis, 87, 564 - 568
Interplay of Age and Sex With Clinic and Ambulatory Blood Pressure and Mortality.
Journal article
Böhm M. et al, (2026), Hypertension
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality.
Journal article
Lauder L. et al, (2026), Hypertension
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis.
Journal article
Neuen BL. et al, (2026), JAMA, 335, 233 - 244
